Published in Drug Law Weekly, February 21st, 2006
Those impacted were enrollees with prescriptions for certain classes of drugs which would normally have required prior authorization or so-called "step therapy" before being approved. The transition policy allowed a 30-day grace period during which the plan member was not subject to those requirements.
Humana, Inc., (HUM) has announced that it has taken the initiative to expand its transition policy from 30 days to 60 days for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.